About the National Data
Baseline: 48.0 percent of adolescents aged 13 through 15 years received recommended doses of the HPV vaccine by 2018
Target: 80.0 percent
Maintain consistency with national programs, regulations, policies, or laws
The National Immunization Survey-Teen (NIS-Teen) collects vaccination information for adolescents aged 13–17 years in the 50 states, the District of Columbia, selected local areas, and selected territories, using a random-digit-dialed sample of landline and, starting in 2011, cellular telephone numbers. Starting in 2018, only cellular phone numbers were used. Parent/guardian respondents provide vaccination and sociodemographic information on adolescents. After the parent/guardian grants permission to contact their child's vaccination provider(s), a questionnaire is mailed to that provider to obtain a vaccination history from the medical record. Data for this measure were restricted to adolescents aged 13–15 and weighted to represent the population of adolescents age 13–15, with adjustments for households with multiple telephone lines and mixed telephone use (landline and cellular), household nonresponse, and exclusion of households without telephone service. In December 2016, the Advisory Committee on Immunization Practices (ACIP) updated the human papillomavirus (HPV) vaccine recommendation to include a 2-dose schedule for immunocompetent adolescents initiating the vaccination series before their 15th birthday. Three doses are still recommended for persons initiating the series at ages 15 through 26 years or who are immunocompromised. This measure tracks the proportion of adolescents aged 13–15 years receiving 2 or 3 doses of HPV vaccine as recommended.